AC Immune (ACIU) Total Non-Current Liabilities (2015 - 2026)

AC Immune (ACIU) has 12 years of Total Non-Current Liabilities data on file, last reported at $17.4 billion in Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 91808.1% year-over-year to $17.4 billion in Q1 2026; TTM through Mar 2026 was $17.4 billion, a 91808.1% increase from a year earlier, with the FY2025 full-year figure at $17.7 billion, up 86979.49% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $17.4 billion, down from $18.4 billion in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for ACIU reached as high as $18.4 billion in Q4 2025 and fell as low as $2.0 million in Q3 2022.
• Historically, Total Non-Current Liabilities has averaged $3.4 billion across 5 years, with a median of $15.1 million in 2024.
• Across the five-year window, Total Non-Current Liabilities slumped 99.98% in 2022 and surged 170677.33% in 2023, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $5.7 million in 2022, then jumped by 170677.33% to $9.7 billion in 2023, then slumped by 99.79% to $20.3 million in 2024, then jumped by 90231.36% to $18.4 billion in 2025, then slipped by 5.13% to $17.4 billion in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $17.4 billion in Q1 2026, $18.4 billion in Q4 2025, and $13.6 million in Q3 2025.